Vincenza Guzzardo
Overview
Explore the profile of Vincenza Guzzardo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
2869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmaso B, Scarpa M, Pellegrini V, Stepanyan A, Salmaso R, Kotsafti A, et al.
Sci Rep
. 2024 Nov;
14(1):29821.
PMID: 39616209
Lynch syndrome is rarely associated with rectal cancer (RC) and thus, metachronous RC has been scarcely investigated. This study aimed to analyze the mucosal immune microenvironment in sporadic and metachronous...
2.
Becherucci G, Ruffolo C, Scarpa M, Scognamiglio F, Stepanyan A, Maretto I, et al.
Surgery
. 2024 Nov;
178():108902.
PMID: 39572264
Background: Transanal excision of rectal cancer can be considered the definitive surgical treatment if the depth spread is T1 or lower, and the lesion is completely included within the resection...
3.
De Simoni O, Scarpa M, Castagliuolo I, Stepanyan A, Angriman I, Kotsafti A, et al.
Cancer
. 2024 Apr;
130(13):2272-2286.
PMID: 38644692
Background: Long-term daily use of aspirin reduces incidence and mortality due to colorectal cancer (CRC). This study aimed to analyze the effect of aspirin on the tumor microenvironment, systemic immunity,...
4.
Martini A, Prasai K, Zemla T, Ahmed F, Elnagar M, Giama N, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201652
Cholangiocarcinoma (CCA), the second most common primary liver tumor, is associated with a dismal outcome, and useful prognostic markers are not currently available in clinical practice. SerpinB3, a serine protease...
5.
Scanu A, Luisetto R, Pavan M, Guarise C, Beninatto R, Giraudo C, et al.
Sci Rep
. 2023 Nov;
13(1):20692.
PMID: 38001135
Osteoarthritis (OA) is a chronic degenerative joint disease characterized by pain and cartilage damage. Intra-articular (i.a) viscosupplementation with hyaluronic acid (HA) is frequently used for the management of OA. Preclinical...
6.
Spolverato G, Fassan M, Scarpa M, Stepanyan A, De Simoni O, Scognamiglio F, et al.
Br J Surg
. 2023 Jul;
110(11):1490-1501.
PMID: 37478362
Background: Colon cancer in young patients is often associated with hereditary syndromes; however, in early-onset rectal cancer, mutations of these genes are rarely observed. The aim of this study was...
7.
Spolverato G, Fassan M, Capelli G, Scarpa M, Negro S, Chiminazzo V, et al.
Int J Surg
. 2023 Apr;
109(3):323-332.
PMID: 37093072
Background: Studies evaluating sex differences in colorectal cancer (CRC) tumor microenvironment are limited, and no previous study has focused on rectal cancer patients' constitutive immune surveillance mechanisms. The authors aimed...
8.
Pizzi M, Vianello F, Lorenzi L, Binotto G, Sbaraglia M, Scarmozzino F, et al.
Br J Haematol
. 2023 Mar;
202(1):147-152.
PMID: 36916680
Accessory spleens (AcS) may play a relevant role in immune thrombocytopenia (ITP) and possibly contribute to ITP relapse following splenectomy. Little is known about the immune microenvironment of AcS in...
9.
Lunardi F, Abbrescia D, Vedovelli L, Pezzuto F, Fortarezza F, Comacchio G, et al.
Biomolecules
. 2023 Jan;
13(1).
PMID: 36671482
Chronic rejection (CR) is the main culprit for reduced survival and quality of life in patients undergoing lung transplantation (Ltx). High-throughput approaches have been used to unveil the molecular pathways...
10.
Arpa G, Fassan M, Guerini C, Quaquarini E, Grillo F, Angerilli V, et al.
Virchows Arch
. 2022 Aug;
481(6):853-863.
PMID: 35925388
Non-ampullary small bowel adenocarcinoma is a rare neoplasm with an ominous prognosis, whose incidence is higher in some chronic immuno-inflammatory conditions, such as coeliac and Crohn's disease. Recently, claudin 18.2,...